Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors

BACKGROUND: Timely detection of chemotherapy-induced peripheral neuropathy (CIPN) is critical to effectively tailor chemotherapy dose levels and offer supportive care. The purpose of this secondary analysis was to determine the reliability and validity of the two Patient-Reported Outcomes Version of...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoerl, Robert, Mazzola, Emanuele, Mitchell, Sandra A., Hong, Fangxin, Salehi, Elahe, McCleary, Nadine, Ligibel, Jennifer A., Reyes, Kaitlen, Berry, Donna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473487/
https://www.ncbi.nlm.nih.gov/pubmed/34568984
http://dx.doi.org/10.1186/s41687-021-00377-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473487/
https://www.ncbi.nlm.nih.gov/pubmed/34568984
http://dx.doi.org/10.1186/s41687-021-00377-z

Ejemplares similares